The origin and evolution of assessment criteria for persistent, bioaccumulative and toxic (PBT) chemicals and persistent organic pollutants (POPs).

General public concern over the effects of persistent chemicals began in the early 1960s. Since then, significant scientific advances have increased our understanding of persistent, bioaccumulative, and toxic (PBT) chemicals and the properties and processes that influence their fates in, and adverse effects on, human health and the environment. In addition to the scientific advances, a number of legislations and agreements for national, international, and global identification and control of PBT chemicals have been adopted. However, some of the rationales and thoughts that were relied upon when the first criteria were developed to identify and categorize PBT chemicals and then POPs (persistent organic pollutants) have not been carried forward. Criteria have been based upon available data of neutral hydrophobic substances as reference chemicals, derived under laboratory conditions. They evolved over the last decades due to the diversification of the protection aims under various national regulatory frameworks and international agreements, advances in methods for estimation of physical/chemical properties, and the identification of chemicals which are non-traditional POPs. Criteria are not defined purely by science; they also are subject to the aims of policy. This paper offers a historical perspective on the development of criteria for PBT chemicals and POPs. It also offers suggestions for rationalization of protection goals, describes some emerging procedures for identification of compounds of concern, and proposes information that needs to be considered when applying criteria to screening and/or evaluation of new chemicals.

Development and validation of a herring gull embryo toxicokinetic model for PCBs.

A toxicokinetic model was developed to describe polychlorinated biphenyl (PCB) accumulation by herring gull (Larus argentatus) embryos during development. The model consists of two components, a bioenergetics model that predicts the lipid mass balance of embryo and yolk compartments with time and an empirical toxicokinetic model that describes PCB partitioning between lipid compartments in the egg. The model was calibrated using data on PCB and lipid partitioning between embryo and yolk + albumen at four time points during incubation in herring gull eggs injected with a PCB mixture, combined with data sets on herring gull embryo growth rates and bioenergetic demands with time. The model was validated using independent data consisting of maternally exposed, field-incubated Lake Superior herring gull eggs that varied in incubation ages over the range of 8.5 d to pipping age (26-28 days). PCB concentrations in 6-9 d embryos were nearly an order of magnitude less than predicted by equilibrium lipid partitioning between the embryo and yolk + albumen compartments of the eggs. PCB concentrations in embryos were adequately predicted by equilibrium partitioning, however, for eggs incubated for 23-28 d. An empirical relationship was developed to account for the apparent nonequilibrium behaviour of PCBs during early development. The model was sensitive to the mass of yolk lipids and the mass of PCBs deposited to fresh eggs and much of the variability in embryo PCB concentrations could by explained by accounting for variability in these input parameters. Consistent with experimental data for other avian species, the model predicts that the highest PCB concentrations in the embryo/chick occur during pipping or soon after when yolk lipids have been completely resorbed by the embryo.